Company Profile
Updated: 27-OCT-09Ferrer Internacional S.A.
Non-Quoted Public Company
Edifici L'Illa, Diagonal 549, 5a planta, Barcelona, E-08029, Spain
()34 93 600 37 00, 34 93 490 89 33 fax, http://www.ferrergrupo.com
Primary SIC: Pharmaceutical Preparations, Primary NAICS: Pharmaceutical Preparation Manufacturing
Description: Manufacturing: Research, production and sale of pharmaceuticals and pharmaceutical raw materials
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
Publication No. WO/2009/077484 Published on June 25, Assigned to FERRER INTERNACIONAL for Cyano Piperidinyl-Phenil-Oxazolidinone, Usage (Spanish Inventors)
US Fed News Service, Including US State News; 11/9/2009; 422 words; ...oxazolidinone and use thereof. The patent has been assigned to FERRER INTERNACIONAL S.A., City, Spain. According to an abstract posted...invention also discloses polymorphic forms of the compound (S)-N-{3-[4-(4-cyano-piperidin-1 -yl...
Vasogen Raises $16M Ahead Of Celacade Launch In Europe.
BIOWORLD Today; 11/3/2009; 1188 words; ...premium to the stock's Thursday closing price...dropped Vasogen's shares (NASDAQ...with partner Grupo Ferrer Internacional SA, expected in the...Barcelona, Spain-based Ferrer for five years after...exposing a patient's cells to oxidative...
Other News To Note.
BIOWORLD Today; 11/3/2009; 1101 words; ...bacterium using ImmPORT's whole-proteome microarray...platform. Invitrogen's service will support...France, and Grupo Ferrer Internacional SA, of Barcelona...Going forward, Ferrer will manage and fund...the new company's vice president of...
Publication No. WO/2009/118359 Published on Oct. 1, Assigned to FERRER INTERNACIONAL, FUNDACION CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CARLOS III for Capsule (Spanish Inventors)
US Fed News Service, Including US State News; 10/5/2009; 419 words; ...Spain, have developed a capsule for the prevention of cardiovascular diseases. The patent has been assigned to FERRER INTERNACIONAL S.A., Barcelona, Spain, and FUNDACION CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CARLOS III, Madrid...
Ferrer international business to amount for 50% of 2009 sales.
ADP News Spain; 9/1/2009; 365 words; Ferrer international business to...sales of Spanish laboratory Ferrer Internacional are expected to amount for 50% of the company's turnover in 2009, the executive...6% of it corresponded to Ferrer's international business...
Recent News Articles
- Grupo Ferrer to commercialize VasogenOs Celacade in EU and Latin America.(Grupo Ferrer Internacional SA )(Brief article)
Pharma Marketletter - April 23, 2007 - NicOx expands R&D accord with GFI.(NicOx S.A., Grupo Ferrer Internacional)(Brief Article)
Pharma Marketletter - September 26, 2005 - NicOx and Ferrer in dermatology deal.(Ferrer Internacional S.A.)(Brief Article)
Pharma Marketletter - May 10, 2004 - Ferrer Internacional's CerAxon will Corner the Neuroprotectant Drug Market in 2013; Use of Combination Therapies for Acute Ischemic Stroke Also Will Contribute to Market Growth, According to a New Study from Decision Resources.
PR Newswire - March 22, 2004
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning
